David Hallal serves as Executive at ALEXION PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, David Hallal has executed 164 insider transactions totaling $64.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 21, 2010 involved selling 916 shares valued at $50.2K.
David Hallal currently holds 1,669,649 shares of ALEXION PHARMACEUTICALS INC (ALXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Hallal has been a net seller of ALXN stock. They have purchased $0 and sold $64.9M worth of shares.
David Hallal's most recent insider trade was on Jun 21, 2010, when they sold 916 shares at $54.81 per share.
Get notified when new Form 4 filings are submitted
| $16.32 |
| Discretionary |
| Mar 2, 2010 | ALXN | $518.0K | Sale | 10,000 | $51.80 | Discretionary |
| Feb 16, 2010 | ALXN | $299.2K | Sale | 6,242 | $47.93 | Discretionary |
| Jan 28, 2010 | ALXN | $0 | Award | 6,000 | $N/A | Discretionary |
| Jan 19, 2010 | ALXN | $10.7K | Sale | 227 | $47.22 | Discretionary |
| Jan 11, 2010 | ALXN | $52.0K | Sale | 1,088 | $47.78 | Discretionary |
| Dec 21, 2009 | ALXN | $43.8K | Sale | 916 | $47.79 | Discretionary |
| Dec 11, 2009 | ALXN | $464.0K | Sale | 10,000 | $46.40 | Discretionary |
| Dec 11, 2009 | ALXN | $163.2K | Option Exercise | 10,000 | $16.32 | Discretionary |
| Jul 27, 2009 | ALXN | $371.5K | Sale | 8,640 | $43.00 | Discretionary |
| Jul 16, 2009 | ALXN | $9.3K | Sale | 238 | $38.96 | Discretionary |
| Jun 19, 2009 | ALXN | $30.4K | Sale | 789 | $38.47 | Discretionary |
| Jun 11, 2009 | ALXN | $136.4K | Sale | 3,590 | $38.00 | Discretionary |